Abstract
Digital breast tomosynthesis: a state-of-the-art review
Highlights
Screening asymptomatic women for breast cancer with mammography can reduce cancer-related mortality up to 30%, since breast carcinoma is a progressive disease and early detection enables better prognosis [1,2,3,4,5,6,7]
To overcome the dose issue, manufacturers have developed a synthesized mammography (SM) that provides the benefits of a combined full field digital mammography (FFDM) plus digital breast tomosynthesis (DBT) examination with a reduced radiation exposure; this is a synthesized 2D image generated from the DBT data
Recent studies showed that the screening performances of SM plus DBT are not inferior to those achieved with FFDM plus DBT [46] and it is likely that SM will replace FFDM in the near future, with a remarkable dose reduction
Summary
Marcello Alessandro ORSI1, Cellina M1*, Rosti C1, Gibelli D2, Belloni E3 and Oliva G1 1Department of Radiology , Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco P.zza Principessa Clotilde 3, 20121, Milano, Italy 2Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, V. Mangiagalli 31, Milan, Italy 3Department of Radiology, Civil Hospital, Corso Milano 19, 27029, Vigevano, Italy
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
